Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TH vs THL in first-line HER2-positive metastatic breast cancer
2011-005189-39Phase 3Completed
- Sponsor
- Cancer Trials Ireland
- Start
- Nov 2011
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lapatinib, trastuzumab, paclitaxel in HER2-enriched breast cancer (HER2+), sponsored by Cancer Trials Ireland. Started Nov 2011; status: completed.
02
Drugs
03
Conditions
HER2-enriched breast cancer (HER2+)
Beyond the preview
Go deeper on 2011-005189-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005189-39.